Life Science Investing Enveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross Proceeds
Life Science Investing Enveric Biosciences Announces Publication of Two Peer-Reviewed Articles Highlighting Novel Bioproduction Methods for Neuropsychiatric Drug Discovery
Life Science Investing Enveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND Submission
Life Science Investing Enveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment Conference
Life Science Investing Enveric Biosciences Successfully Completes Pre-IND Dose Range Finding Studies for Lead Candidate EB-003, Targeting Neuropsychiatric Indications
